Search details
1.
Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin.
Mol Cancer
; 16(1): 45, 2017 02 23.
Article
in English
| MEDLINE | ID: mdl-28231799
2.
Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer.
Tumour Biol
; 36(2): 1199-206, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25344212
3.
Risk factors associated with Clostridium difficile infection in adult oncology patients.
Support Care Cancer
; 23(6): 1569-77, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25410088
4.
DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
Carcinogenesis
; 34(5): 1031-8, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23349018
5.
Role of inhibitors of mammalian target of rapamycin in the treatment of luminal breast cancer.
Anticancer Drugs
; 24(8): 769-80, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23838677
6.
Guidelines for the management of breakthrough pain in patients with cancer.
J Natl Compr Canc Netw
; 11 Suppl 1: S29-36, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23520183
7.
Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone.
Invest New Drugs
; 30(2): 729-40, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-20960029
8.
First-line bevacizumab-containing therapy for triple-negative breast cancer: analysis of 585 patients treated in the ATHENA study.
Oncology
; 82(4): 218-27, 2012.
Article
in English
| MEDLINE | ID: mdl-22508241
9.
Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies.
Ther Adv Med Oncol
; 14: 17588359221086911, 2022.
Article
in English
| MEDLINE | ID: mdl-35356259
10.
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer.
Cancer Metastasis Rev
; 29(4): 751-9, 2010 Dec.
Article
in English
| MEDLINE | ID: mdl-20922461
11.
The role of RANK-ligand inhibition in cancer: the story of denosumab.
Oncologist
; 16(2): 136-45, 2011.
Article
in English
| MEDLINE | ID: mdl-21285392
12.
Final overall survival results and effect of prolonged (≥ 1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial.
Breast Cancer Res Treat
; 130(1): 133-43, 2011 Nov.
Article
in English
| MEDLINE | ID: mdl-21830015
13.
Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study.
Clin Cancer Res
; 15(1): 307-14, 2009 Jan 01.
Article
in English
| MEDLINE | ID: mdl-19118059
14.
Phase I pharmacokinetic/pharmacodynamic study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor tyrosine kinase, in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in first-line treatment of patients with metastatic colorectal cancer.
Clin Cancer Res
; 14(1): 215-23, 2008 Jan 01.
Article
in English
| MEDLINE | ID: mdl-18172273
15.
Prognostic value of KIT expression in small cell lung cancer.
Lung Cancer
; 56(3): 405-13, 2007 Jun.
Article
in English
| MEDLINE | ID: mdl-17420067
16.
Primary pulmonary artery sarcoma: report of three cases and review of the literature.
Clin Lung Cancer
; 8(4): 277-81, 2007 Jan.
Article
in English
| MEDLINE | ID: mdl-17311694
17.
Role of anthracyclines in the era of targeted therapy.
Cardiovasc Toxicol
; 7(2): 56-60, 2007.
Article
in English
| MEDLINE | ID: mdl-17652804
18.
Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck.
J Clin Oncol
; 23(24): 5568-77, 2005 Aug 20.
Article
in English
| MEDLINE | ID: mdl-16009950
19.
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
J Clin Oncol
; 23(34): 8636-45, 2005 Dec 01.
Article
in English
| MEDLINE | ID: mdl-16275937
20.
Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
Eur J Cancer
; 41(3): 453-60, 2005 Feb.
Article
in English
| MEDLINE | ID: mdl-15691646